Cargando…

Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells

Atomoxetine (ATX) is a non-stimulant drug used in the treatment of attention-deficit/hyperactivity disorder (ADHD) and is a selective norepinephrine reuptake inhibitor. It has been shown that ATX has additional effects beyond the inhibition of norepinephrine reuptake, affecting several signal transd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corona, Juan Carlos, Carreón-Trujillo, Sonia, González-Pérez, Raquel, Gómez-Bautista, Denise, Vázquez-González, Daniela, Salazar-García, Marcela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737196/ https://www.ncbi.nlm.nih.gov/pubmed/31506604 http://dx.doi.org/10.1038/s41598-019-49609-9

Ejemplares similares

Atomoxetine and citalopram alter brain network organization in Parkinson’s disease
por: Borchert, Robin J, et al.
Publicado: (2019)

Treatment of Children and Adolescents with Epilepsy with Atomoxetine
por: Park, Kee Jeong, et al.
Publicado: (2020)

Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease
por: Borchert, Robin J, et al.
Publicado: (2016)

Atomoxetine restores the response inhibition network in Parkinson’s disease
por: Rae, Charlotte L., et al.
Publicado: (2016)

Targeting impulsivity in Parkinson’s disease using atomoxetine
por: Kehagia, Angie A., et al.
Publicado: (2014)

A critical appraisal of atomoxetine in the management of ADHD
por: Childress, Ann C
Publicado: (2015)

Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015)

Off-label use of atomoxetine in adults: is it safe?
por: Dadashova, Rana, et al.
Publicado: (2012)

Improving Response Inhibition in Parkinson’s Disease with Atomoxetine
por: Ye, Zheng, et al.
Publicado: (2015)

Atomoxetine in abstinent cocaine users: Sex differences
por: DeVito, Elise E., et al.
Publicado: (2017)

The effect of atomoxetine on random and directed exploration in humans
por: Warren, Christopher M., et al.
Publicado: (2017)

Pioglitazone enhances brain mitochondrial biogenesis and phase II detoxification capacity in neonatal rats with 6-OHDA-induced unilateral striatal lesions
por: Vázquez-González, Daniela, et al.
Publicado: (2023)

Atomoxetine: a novel treatment for child and adult ADHD
por: Ledbetter, Marcialee
Publicado: (2006)

Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults
por: Schelleman, Hedi, et al.
Publicado: (2013)

Amphetamine Positive Urine Toxicology Screen Secondary to Atomoxetine
por: Fenderson, Joshua L., et al.
Publicado: (2013)

The influence of paroxetine on the pharmacokinetics of atomoxetine and its main metabolite
por: TODOR, IOANA, et al.
Publicado: (2015)

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
Publicado: (2020)

Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
por: Byun, Jung‐Ick, et al.
Publicado: (2019)

The effect of atomoxetine on cognitive function in patients with multiple sclerosis
por: Mohammadian Nejad, Ehsan, et al.
Publicado: (2023)

Proteomic Network Analysis of Alzheimer’s Disease Cerebrospinal Fluid Reveals Alterations Associated with APOE ε4 Genotype and Atomoxetine Treatment
por: Dammer, Eric B., et al.
Publicado: (2023)

Atomoxetine modulates the relationship between perceptual abilities and response bias
por: Guedj, Carole, et al.
Publicado: (2019)

Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
por: Suzuki, Shiho, et al.
Publicado: (2020)

Atomoxetine-induced focal seizures with contralateral hypoperfusion and hyper-CKemia
por: Finsterer, Josef, et al.
Publicado: (2020)

Transition from Methylphenidate to Atomoxetine: reasons for switching and clinical outcome
por: Cassar, Fabrizia, et al.
Publicado: (2021)

Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review
por: Treuer, Tamás, et al.
Publicado: (2016)

Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats
por: Hou, Qing-Xian, et al.
Publicado: (2016)

Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy
por: Bro, Søren Pauli, et al.
Publicado: (2015)

Multi-spectroscopic characterization of bovine serum albumin upon interaction with atomoxetine()
por: Buddanavar, Arunkumar T., et al.
Publicado: (2017)

Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease
por: O’Callaghan, Claire, et al.
Publicado: (2021)

Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine
por: Ekinci, Ozalp, et al.
Publicado: (2020)

Cognitive Test Solution in Mice with Different Brain Weights after Atomoxetine
por: Perepelkina, Olga V., et al.
Publicado: (2023)

Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
por: Price, Maxwell Z., et al.
Publicado: (2023)

Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
por: Ye, Zheng, et al.
Publicado: (2016)

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
por: Dittmann, Ralf W, et al.
Publicado: (2009)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
por: Hammerness, Paul, et al.
Publicado: (2009)

Atomoxetine for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children with ADHD and dyslexia
por: Sumner, Calvin R, et al.
Publicado: (2009)

Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
por: Kohn, Michael R., et al.
Publicado: (2012)

Effects of Atomoxetine on Hyper-Locomotive Activity of the Prenatally Valproate-Exposed Rat Offspring
por: Choi, Chang Soon, et al.
Publicado: (2014)

Effect of Atomoxetine on Hyperactivity in an Animal Model of Attention-Deficit/Hyperactivity Disorder (ADHD)
por: Moon, Su Jin, et al.
Publicado: (2014)

Pilot study of atomoxetine in patients with Parkinson’s disease and dopa-unresponsive Freezing of Gait
por: Revuelta, Gonzalo J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e5cr0rp3u9q8spdp4s3d85kt0e